Home Business

Aegon Religare to enter health ins, launch upto three products

Private life insurer, Aegon Religare, plans to enter the health insurance segment while continuing to focus on term insurance products, a senior company official said. "We are looking to enter the health insurance segment and will be filing upto three health insurance products with the IRDA in the last quarter of this fiscal," Aegon Religare Life Insurance"s Chief Financial Officer, K S Gopalakrishnan, told PTI here. - Reliance Life IPO likely in Q1 of next fiscal: Ghosh - Central Bank to raise Rs 400 cr through bonds in 2 months - Insurance agents to stage dharna tomorrow - AIG lowers Fed debt, transfers non-US life insurers - Panel for doing away with insurance commission - BPCL rises 2.6% Sensex pares gains; Hindalco up 4% Loan prepayment does not violate competition laws:Banks SRK stands by his IPL remarks, says India a welcoming place Obama proposes substantial jump in aid to Pak Oil rises on bullish US manufacturing data Aegon Religare presently has four term products in its portfolio of which it is selling exclusively one term product, i-Term, online. "The plan is cheaper than other products available in the market as we have been able to eliminate the distribution cost," Gopalakrishnan said. "This is a significant thing we are betting on," he said. The minimum sum assured is of Rs 10 lakh and the entry age is a minimum of 18 years and maximum of 50 years. The company which has a current capital base of Rs 465 crore is planning to infuse Rs 60 crore by the end of this fiscal, Gopalkrishnan said. It is also increasing its agents strength to 9,000 from the present 5,000 by end-fiscal, he said.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Markets marginally down
The Sensex is now at 17,664, down 23 points. The NSE Nifty is at 5,268, down nine points.
Popular Articles

Activists hold Rajdhani hostage
Five-hour tense standoff in rural Bengal finally ends without violence.

Natco Pharma FY09 net rises 8.5% at Rs 44 cr
Hyderabad-based drug maker Natco Pharma reported an 8.5 per cent rise in its consolidated net profit at Rs 43.98 crore for the year ended March 2009, compared with Rs 40.52 crore posted in the previous year.